Endogenous production of cytotoxic factor in mice induced by a combination of interferon-gamma and heterologous fibrinogen.
The ability of heterologous fibrinogen in combination with interferon (IFN)-gamma to induce endogenous production of cytotoxic factor was examined. Heterologous but not homologous fibrinogen induced high production of cytotoxic factor in IFN-gamma-primed mice. The cytotoxic activity was maximal 1 h after this triggering. The LD50 value of heterologous fibrinogen in mice was greater than 250 mg/kg i.v. But heterologous fibrinogen induced antibody, causing anaphylaxis. Therefore, the effect of successive injections of fibrinogens from a different species was tested. Cytotoxic factor could be produced repeatedly by successive treatments with a combination of IFN-gamma and heterologous fibrinogen from one species for 1 week, although the cytotoxic activity induced by successive injections gradually decreased. After the decrease of the triggering effect of heterologous fibrinogen of one species, heterologous fibrinogen from a different species could induce cytotoxic activity at the same level as that after the first triggering. Thus, a combination of IFN-gamma and heterologous fibrinogen is effective for cytotoxic factor production, provided different heterologous fibrinogens are used successively. This combination should be useful for endogenous cytotoxic factor production in clinical trials.
D000818:Animals; D002460:Cell Line; D003602:Cytotoxicity, Immunologic; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004357:Drug Synergism; D005340:Fibrinogen / Q000008:administration & dosage* / Q000633:toxicity; D007371:Interferon-gamma / Q000008:administration & dosage*; D055646:Killer Factors, Yeast; D051379:Mice; D008809:Mice, Inbred C3H; D014176:Protein Biosynthesis; D011506:Proteins
D055646:Killer Factors, Yeast; D011506:Proteins; D007371:Interferon-gamma; D005340:Fibrinogen